2024-05-15 14:00:00 ET
Summary
- CVS Health's recent earnings miss and revised guidance caused a steep sell-off in the stock, which now may present a buying opportunity for long-term investors.
- Despite the miss, the company saw positive growth in total revenues and medical memberships during the quarter.
- The decline in cash from operations puts the dividend safety under some pressure, but it remains secure with projected cash from operations of $10.5 billion.
- CVS offers investors double-digit upside to my price target of $76, slightly above Wall Street's price target of $71.
Investment Thesis
Read the full article on Seeking Alpha
For further details see:
CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity